Some under-the-radar healthcare stocks are unlikely attractive picks, according to Renaissance Macro Research chairman Jeff deGraaf. The technical analyst, who studies charts to make buying and selling decisions, said on CNBC's "Squawk on the Street" on Monday that while the overall sector isn't fairing as well as he'd like, there's still value in names apart from the top line pharmaceuticals.
mountain Healthcare equipment stocks are some of the most attractive picks in the overall sector, according to Renaissance Macro Research chief Jeff DeGraaf. So far this year, all three stocks have climbed considerably, with Bruker and Stryker adding 15% and 17.5%, respectively. Boston Scientific, meanwhile, has climbed 8.3% from the beginning of 2023. SYK YTD mountain Stryker is leading the pack of out Jeff DeGraaf's picks, with a gain of roughly 17.5% so far this year.